Understanding the dynamics of phase separation during infection sheds light on host-pathogen interactions and immune responses, potentially facilitating the development of antiviral strategies.
Wave Life Sciences (WVE) announced clinical trial application, CTA, approval and initiation of the Phase 1 INLIGHT clinical trial of WVE-007 in obesity. WVE-007 is a long-acting GalNAc-conjugated ...